Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.57
- Piotroski Score 5.00
- Grade Buy
- Symbol (ILMN)
- Company Illumina, Inc.
- Price $130.10
- Changes Percentage (0.45%)
- Change $0.58
- Day Low $128.55
- Day High $131.55
- Year High $144.15
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/07/2024
- Fiscal Year End N/A
- Average Stock Price Target $175.00
- High Stock Price Target $562.00
- Low Stock Price Target $58.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$8.14
- Trailing P/E Ratio -13.97
- Forward P/E Ratio -13.97
- P/E Growth -13.97
- Net Income $-1,161,000,000
Income Statement
Quarterly
Annual
Latest News of ILMN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Illumina, Inc. (NASDAQ:ILMN): A Non-Tech Stock With Long-Term Investment Potential
Goldman Sachs identified non-tech AI stocks with long-term potential, emphasizing AI's impact beyond tech. Illumina, Inc. (NASDAQ:ILMN) uses AI for genetic analysis. It ranks 9th on the list, but othe...
By Yahoo! Finance | 14 hours ago -
Goldman Thinks Illumina, Inc. (ILMN) Is A Long-Term AI Stock Set To Rally Eventually
Insider Monkey recently analyzed Beyond the Tech Giants to identify 35 non-tech AI investment opportunities, including Illumina, Inc. (NASDAQ:ILMN). Goldman Sachs predicts AI's impact on various secto...
By Yahoo! Finance | 3 days ago -
Illumina, Inc. (ILMN): Is This Cheap Robotic Stock a Good Buy Right Now?
A list of 10 cheap robotics stocks to buy was recently compiled, analyzing Illumina, Inc. (NASDAQ:ILMN) among others. The growth of industrial robots globally is driven by lower costs and increased pr...
By Yahoo! Finance | 4 weeks ago
